ABSTRACT The DNA sequence coding for hepatitis B virus surface antigen (HBsAg) was placed under control of the repressible acid phosphatase promoter of the yeast Saccharomyces cerevisiae in a plasmid capable ofautonomous replication in both yeast and Escherichia coli Yeast transformed by this plasmid synthesized up to 5 x 105 molecules per cell of immunologically active HBsAg polypeptide in phosphate-free medium. The HBsAg polypeptides produced in the yeast cells were assembled into 20-to 22-nm spherical or oval particles and were immunogenic.
Hepatitis B virus (HBV) causes serious human liver disease, including hepatoma. Infection by this virus is a worldwide health problem, and a considerable number of people, particularly in Southeast Asia, the Middle East, and some areas of Africa, suffer from transient or chronic HBV infection. The infectious agent has been identified as a 40-to 50-nm spherical particle, called the Dane particle, that is detected in patients' blood. The Dane particle contains a 3.2-kilobase (kb) circular DNA that has a single-stranded gap (1, 2) .
Intensive efforts have been made to understand the structural and behaviorial characteristics ofthis virus in order to control the disease and to produce vaccines. However, such efforts have been hampered seriously by the fact that HBV replicates only in human and chimpanzee livers.
The viral genome has been converted to double-stranded form by filling-in and has been cloned and propagated in Escherichia coli (3) (4) (5) (6) . Analyses of the cloned HBV genome have brought new insights into the structure and function ofthis viral genome. At the same time, it was expected that vaccines might be produced in E. coli cells by allowing expression ofthe cloned surface antigen (HBsAg) gene. Despite many efforts, however, production of vaccines in E. coli has not succeeded because, in E. coli cells, the HBsAg gene product seems to be either unstable or to cause effects deleterious to the host, or both. In the present study, we report a yeast system that allows expression of the HBsAg gene.
One ofthe yeast acid phosphatases [APase; orthophosphoricmonoester phosphohydrolase (acid optimum), EC 3.1.3.2] is an exocellular 60-kilodalton polypeptide designated P-60; the expression of the gene for P-60 is controlled by the level of inorganic phosphate (7) (8) (9) (10) (11) (12) . We took this gene, freed its promoter from the coding sequence of the polypeptide, and joined the promoter with the HBsAg gene in such a way that free, nonfusion polypeptides of HBsAg were made. The promoterHBsAg gene complex was inserted into a shuttle vector that replicates in both yeast and E. coli and then was used to transform yeast. The transformants produce a large quantity of HBsAg polypeptide in low P1 medium, and the HBsAg is assembled into spherical or oval immunogenic particles.
MATERIALS AND METHODS
Strains and Media. Yeast strain AH22 (a leu2 his4 cani cir') (13) and its APase constitutive derivative, AH22 pho80, were from our stock collection. Burkholder minimal medium (10) 30 'C. The spheroplasts were collected by centrifugation and lysed in 1 ml of0.1% Triton X-100/50 mM phosphate, pH 7.2/ 1 mM phenylmethylsulphonyl fluoride. The lysate was clarified by centrifugation at 7,000 rpm for 10 min. Protein concentration was measured by the Lowry method. Detection of HBV Proteins. Radioimmunoassay for HBV surface antigen (HBsAg), core antigen (HBcAg), and e antigen (HBeAg) (1) were performed on samples of yeast extract containing 50 ,ug ofproteins by using the Abbott radioimmunoassay kit. Electron microscopy of HBsAg particles was performed as described by Hirschman et al. (22) .
RESULTS
Construction of the Expression Plasmid. The yeast-E. coli shuttle vector pAT77 contains a fragment ofyeast DNA (EcoRIBamHI-Sal I fragment) that carries the sequence of the NH2-terminal region ofthe P-60 polypeptide and its upstream control region ( Fig. 1B) (12) . A Goldberg-Hogness sequence T-A-T-A-T-A-A, which is believed to be the eukaryotic promoter sequence (23), is located at positions -95 to -101 when the A in the initiator codon AUG for the P-60 polypeptide is assigned position + 1. The sequence T-T-C-A-T-C-T-C-T, believed to be the transcription initiation site (23), is located at positions -51 A Eco RI' to -59. The unique Sal I site located at position +83 in the P-60 coding region defines the junction between this DNA and pBR322. To allow production of nonfused HBsAg, we completely eliminated the P-60 polypeptide coding sequence and replaced it with the HBsAg coding sequence that carries the initiator codon. To do this, we cleaved pAT77 with Sal I, treated it with exonuclease BAL-31 so that 85-130 bp of DNA were removed from the Sal I cleavage-site ends, and then ligated the products with Xho I linkers. The exact deletion end points were determined by DNA sequence analyses. One of the resulting plasmids, pAM82, which had lost 116-bp ofthe P-60 gene from the Sal I site ofpAT77, was found to have the intact APase promoter sequence. This plasmid was chosen for further studies as an expression vector. The 3' terminus of the APase promoter region was found to be at position -33, where a Xho I linker had been joined (Fig. 1) .
Whole HBV DNA was recovered from pHBV4 by digestion with Xho I. Fig. 2A shows the cleavage sites of some restriction enzymes and the locations of the coding sequences of HBsAg and HBcAg. The Xho I terminus is located 27 bp upstream of the initiation codon for HBsAg. HBsAg consists of 226 amino acids.
The whole HBV DNA with Xho I termini was inserted into the Xho I site of the pAM82 expression vector, and the product was named pAH203. Similarly, a 1.3-kb Xho I-BamHI fragment carrying the HBsAg gene was inserted into the same site of pAM82, and the product was named pAH301. In this case, the ATP/100 ug of bovine serum albumin per ml for 12 hr at 180C. The ligation mixture was transformed into E. coli strain x1776, and ampicillinresistant colonies were selected. From these transformants, cells that carry a plasmid whose Sal I site had been replaced by anXho I site were used for further tests. The deletion endpoints were determined by sequence analysis (24) . Finally, plasmid pAM82 was selected. This plasmid lost the entire P-60 polypeptide coding sequence because of a 116-bp deletion starting from its Sal I site. The heavy black segment represents the cloned yeast APase DNA. An arrow above the APase region shows the direction of transcription started by the APase promoter. (B) Sequence of the yeast APase promoter region carried in pAT77 and pAM82. The vector plasmid pAT77 carries an -2.8-kb DNA fragment (EcoRI-BamHI-Sal I) from the yeastPHO5 locus, where the APase promoter and coding sequence for P-60 polypeptide are located. Only a portion of the DNA sequence around the 5' noncoding and NH2-terminal region of the P-60 polypeptide is shown. pAT77 has one Sal I site, located 83 bp downstream of the P-60 coding sequence, that is used as the junction between yeast and pBR322 DNA. In pAM82, DNA to the right of position -32 (in the figure) was deleted by BAL-31 digestion. This terminus wasjoined to pBR322 through an Xho I linker. The DNA sequences were determined according to Maxam and Gilbert (24) . The sequence shown with pAT77 has been determined independently by Kramer et al. (25) ; asterisks indicate the initiation sites for mRNA synthesis as described (25 BamHI terminus of the 1.3-kb fragment was converted to an Xho I terminus by filling in with T4 DNA polymerase, followed by ligation with Xho I linkers. In the resulting recombinant plasmids, the genetic elements were joined in the following order: APase promoter-Xho I linker-HBsAg gene-Xho I linker-pBR322 (Fig. 2B) .
The recombinant plasmids propagated in E. coli x1776 were transformed into a yeast recipient strain, AH22, or into its APase constitutive derivative, AH22 pho80, by standard transformation procedure, selecting for Leu+ colonies.
Induction and Production of HBsAg in Yeast Cells. The Leu+ cells were grown in liquid medium and then induced in phosphate-free medium. At appropriate times, cells were collected, converted to spheroplasts, and lysed by Triton X-100. After a high-speed centrifugation, the extracts were examined by radioimmunoassay for HBsAg ( (27) . Some Properties ofthe HBsAg Produced in Yeast Cells. The HBsAg in the yeast extracts was precipitated by anti-HBsAg antibody and examined by electron microscopy. Aggregates of 20-to 22-nm spherical or oval particles were observed (Fig. 3) , which did not appear in control samples. Thus, HBsAg produced by yeast seemed to be assembled into particles similar in size and shape to those small particles found in HBV-infected patients' sera. Note, however, that these particles do not carry DNA and are smaller than Dane particles (28) .
The yeast extract containing HBsAg was injected subcutaneously into guinea pigs (=400 ng of HBsAg per animal). After two further boosters with a 1-wk interval, the sera were examined for anti-HBsAg antibody titer by using the AUSAB radioimmunoassay (Abbott). The injected animals produced high levels of anti-HBsAg antibody, which proves that the antigen produced in yeast cells was sufficiently immunogenic (Table 2) .
We 
